These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6971118

  • 21. The diagnosis of cutaneous T-cell lymphoma by morphometric evaluation of the cellular infiltrate, using semithin sections.
    Lessana-Leibowitch M, Prado A, Palangie A, Lamy F, Flandrin G.
    Br J Dermatol; 1984 May; 110(5):511-21. PubMed ID: 6609710
    [Abstract] [Full Text] [Related]

  • 22. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH, Olson LC, Magro CM.
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [Abstract] [Full Text] [Related]

  • 23. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S, Black RA, Nagao M, Sepassi M, Sharma G, Thornton S, Kim YH, Braverman J.
    J Med Internet Res; 2019 Jan 07; 21(1):e11302. PubMed ID: 30617041
    [Abstract] [Full Text] [Related]

  • 24. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
    Wechsler J, Bagot M, Nikolova M, Parolini S, Martin-Garcia N, Boumsell L, Moretta A, Bensussan A.
    J Pathol; 2003 Jan 07; 199(1):77-83. PubMed ID: 12474229
    [Abstract] [Full Text] [Related]

  • 25. DNA analysis by flow cytometry in cutaneous T-cell lymphomas.
    Ralfkiaer E, Larsen JK, Christensen IJ, Thomsen K, Wantzin GL.
    Br J Dermatol; 1989 May 07; 120(5):597-605. PubMed ID: 2788008
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin.
    Potoczna N, Boehncke WH, Nestle FO, Küenzlen C, Sterry W, Burg G, Dummer R.
    J Cutan Pathol; 1996 Aug 07; 23(4):298-305. PubMed ID: 8864915
    [Abstract] [Full Text] [Related]

  • 29. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK.
    G Ital Dermatol Venereol; 2008 Dec 07; 143(6):375-83. PubMed ID: 19169210
    [Abstract] [Full Text] [Related]

  • 30. Incidence of primary cutaneous T-cell lymphoma in Norway.
    Saunes M, Nilsen TI, Johannesen TB.
    Br J Dermatol; 2009 Feb 07; 160(2):376-9. PubMed ID: 18808419
    [Abstract] [Full Text] [Related]

  • 31. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates.
    Haynes BF, Hensley LL, Jegasothy BV.
    Blood; 1982 Aug 07; 60(2):463-73. PubMed ID: 7046848
    [Abstract] [Full Text] [Related]

  • 32. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
    Arai E, Katayama I, Ishihara K.
    Pathol Res Pract; 1991 May 07; 187(4):451-7. PubMed ID: 1876527
    [Abstract] [Full Text] [Related]

  • 33. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Kuhn A, Goerdt S, Krammer PH, Suri-Payer E.
    Leukemia; 2006 Jun 07; 20(6):1123-9. PubMed ID: 16557241
    [Abstract] [Full Text] [Related]

  • 34. TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+)  CD8(-) phenotype.
    Schrader AM, Jansen PM, Willemze R.
    Br J Dermatol; 2016 Aug 07; 175(2):382-6. PubMed ID: 26931394
    [Abstract] [Full Text] [Related]

  • 35. Cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia: clinical characteristics, temporal relationships, and survival data in a series of 14 patients at Mayo Clinic.
    Chang MB, Weaver AL, Brewer JD.
    Int J Dermatol; 2014 Aug 07; 53(8):966-70. PubMed ID: 24134412
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
    Safai B.
    Clin Bull; 1977 Aug 07; 7(3):91-7. PubMed ID: 308870
    [No Abstract] [Full Text] [Related]

  • 38. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
    Vonderheid EC, Diamond LW, van Vloten WA, Scheffer E, Meijer CJ, Cashell AW, Hardman JM, Lai SM, Hermans J, Matthews MJ.
    Cancer; 1994 Jan 01; 73(1):207-18. PubMed ID: 8275427
    [Abstract] [Full Text] [Related]

  • 39. Sarcoidal tissue reaction in Sézary syndrome.
    Gregg PJ, Kantor GR, Telang GH, Lessin SR, Nowell PC, Vonderheid EC.
    J Am Acad Dermatol; 2000 Aug 01; 43(2 Pt 2):372-6. PubMed ID: 10901727
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.